Cartiva® synthetic cartilage implants were once touted as a groundbreaking solution for patients suffering from hallux limitus or hallux rigidus, a degenerative arthritis that impacts the first metatarsophalangeal joint, or big toe. This condition affects millions of people each year, robbing them of mobility and quality of life.
Cartiva® Toe Implants are synthetic devices designed to alleviate pain and restore mobility for those living with arthritis in the big toe. Unfortunately, instead of relief, many patients have reported debilitating complications, including:
- Infection
- Revision Surgery
- Fragmentation
- Bone Erosion
- Nerve Damage
- Loss of Range of Motion
Patients Report Premature Cartiva® Implant Failures
If your Cartiva® toe implant has failed, leading to pain, reduced mobility, and additional surgeries, you are not alone. Thousands of individuals who received Cartiva® implants for hallux rigidus are experiencing:
- Premature implant failure requiring revision surgery
- Persistent pain and discomfort despite revision surgery
- Loss of mobility and function in the toe
- Defective Design and Materials: Studies suggest that Cartiva® implants degrade and shrink over time, causing instability and ongoing pain.
- Fast-Tracked FDA Approval: Concerns have been raised that the device’s risks were not fully evaluated before being released to the public.
- Failure to Warn: Patients and healthcare providers may not have been sufficiently informed about the likelihood of implant failure.
Contact Us for Help
At Pittman, Dutton, Hellums, Bradley & Mann, P.C., we understand the devastating impact a defective medical device can have on your life. If you or a loved one have suffered due to a failed Cartiva® implant, our experienced attorneys are here to help. We are actively investigating claims and pursuing compensation for those harmed by this defective device.
Call us today at (205) 322-8880 or schedule a free consultation. Let us help you seek justice and hold the manufacturer accountable.
